Close Menu
Home » IQvia

IQvia

Apr 15, 2019

Linguamatics Branching Out With 'Entry Level' Search Tool

Premium

Now a subsidiary of IQvia, NLP vendor Linguamatics also is looking to help precision medicine providers and pharma researchers with phenotype-genotype matching.

Mar 05, 2019

IQvia Launches Genomics Technology Platform

Premium

The new IQvia E360 Genomics build includes a "privacy-preserving" database system and will soon have analytic tools to support genotype-phenotype research.

Feb 12, 2019

IQvia Acquires Linguamatics

CRO and analytics giant IQvia, the product of the IMS Health-Quintiles merger, quietly purchased UK-based bioinformatics company Linguamatics a month ago.

Oct 04, 2018

Genomics England Taps Iqvia for Clinical-Genomic Data Integration

The analytics firm formerly known as Quintiles IMS will offer researchers secure access to Genomics England's de-identified databases in pursuit of precision medicine.

Oct 24, 2016

Illumina, Q2 Solutions to Collaborate on Companion Dx Development

Under the terms of the agreement, Q2 Solutions will develop companion diagnostics on Illumina's MiSeqDx instrument.

Jul 23, 2015

Quest Diagnostics' Q2 Revenues Up 1 Percent; Updates 2015 Guidance

In the second quarter, Quest reported revenues of $1.93 billion and estimated 2015 revenues will be between $7.49 billion and $7.57 billion.

Jul 02, 2015

Quest, Quintiles Launch Clinical Trials Joint Venture Q2 Solutions

The firms aim to establish the second largest lab services firm in the world to aid drugmakers with clinical trials.

Mar 31, 2015

Quintiles, Quest Form Global Lab Services Joint Venture

The joint venture – of which Quintiles will own 60 percent and Quest will own 40 percent – is poised to be the second largest central laboratory services firm in the world.

Aug 05, 2014

Ventana, Quintiles to Offer CDx Testing Services in China for Early Phase Cancer Studies

NEW YORK (GenomeWeb) – Roche subsidiary Ventana Medical Systems has signed an agreement with contract research organization Quintiles to offer companion diagnostic testing services to drug developers performing early stage oncology studies in China.

May 28, 2014

G3 Enrolls 7,500 Participants in Project to Build Detailed 'Omics Map of CVD; Pilot Analysis Underway

Premium

NEW YORK (GenomeWeb) – Global Genomics Group this week said it has finished enrolling a 7,500-patient cohort on which the company will collect and analyze 22 trillion data points, including omics data, and build a detailed network map of atherosclerotic cardiovascular disease (CVD).

Pages

The Scan

Aiming for the Mutations

The chief executive of the National Health Service in England is to call for tumor-agnostic drugs to be "fast-tracked," according to the Times.

Why in Decline?

Researchers in Australia are sequencing the Wollemi pine tree to try to protect it from extinction, Australia's ABC News reports.

Time Off and a Connection

Computerworld ranks Illumina as one of the top midsize organizations to work at in IT.

Genome Research Papers Examine Epigenetic Aging and Method to ID CNVs

In Genome Research this week: links between biological aging and mutations affecting epigenetic regulators; long-read sequencing-based strategy to map chromatin accessibility; and more.

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2019 GenomeWeb LLC.  All Rights Reserved.